The MFWire
Manage Email Alerts | Sponsorships | About MFWire | Who We Are

Subscribe to MFWire.com's News Alerts [click]

Rating:Stowers Bids Adieu to American Century's Fund Board Not Rated 5.0 Email Routing List Email & Route  Print Print
Tuesday, December 29, 2009

Stowers Bids Adieu to American Century's Fund Board

by: Patricia Kelly

James E. Stowers Jr. founder of American Century Investments and a pillar in the mutual fund world for decades retired from his role on American Century's fund board, a company spokesperson confirmed to The MFWire.

James Stowers Jr.
American Century Investments
Board of Directors
Stowers will not be replaced, according to spokeswoman Jackie Hermanson. The board is made up of American Century CEO and president Jonathan Thomas and seven independent directors.

The 85-year-old Stowers launched a family of no-load funds under the name Twentieth Century Mutual Funds in Kansas City, Missouri, in 1958, armed with a mere 24 investors and just $107,000 in cash. The funds laid the groundwork for the company that would ultimately become American Century Investments, officially assuming that name in 2000.

In 1994, following a bout with cancer, Stowers founded the Stowers Institute for Medical Research along with his wife and fellow cancer survivor, Virginia. The $2 billion biomedical research institute supports research surrounding the genes and proteins that control the fundamental processes of living cells in an effort to combat cancer. 

Stay ahead of the news ... Sign up for our email alerts now

 Do You Recommend This Story?

Return to Top
 News Archives
2019: Q4Q3Q2Q1
2018: Q4Q3Q2Q1
2017: Q4Q3Q2Q1
2016: Q4Q3Q2Q1
2015: Q4Q3Q2Q1
2014: Q4Q3Q2Q1
2013: Q4Q3Q2Q1
2012: Q4Q3Q2Q1
2011: Q4Q3Q2Q1
2010: Q4Q3Q2Q1
2009: Q4Q3Q2Q1
2008: Q4Q3Q2Q1
2007: Q4Q3Q2Q1
2006: Q4Q3Q2Q1
2005: Q4Q3Q2Q1
2004: Q4Q3Q2Q1
2003: Q4Q3Q2Q1
2002: Q4Q3Q2Q1
 Subscribe via RSS:
Add to My Yahoo!
follow us in feedly

©All rights reserved to InvestmentWires, Inc. 1997-2019
14 Wall Street | 20th Floor | New York, NY 10005 | P: 212-331-8968 | F: 212-331-8998
Privacy Policy :: Terms of Use